Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunosuppression and the rheumatic diseases

A M Denman

    Annals of the Rheumatic Diseases
    |January 1, 1982
    PubMed
    Summary

    Understanding rheumatoid arthritis is key to using cytotoxic drugs effectively. These drugs might help inflammation but could harm immune responses if the disease is antigen-driven, not a primary immune disorder.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The Malarial Question-Letter from Dr. Denman.

    Texas medical journal (Austin, Tex.)·2023
    Same author

    That Resection: Letter from Dr. A. N. Denman.

    Texas medical journal (Austin, Tex.)·2023
    Same author

    Induction of interferon by lentiviruses.

    Immunology today·2014
    Same author

    Food allergy.

    British medical journal (Clinical research ed.)·2010
    Same author

    Amyloid Disease following Rheumatoid Arthritis with Advanced Arterial Calcification.

    Proceedings of the Royal Society of Medicine·2009
    Same author

    Viruses and autoimmune diseases--adapting Koch's postulates.

    Autoimmunity reviews·2004

    Area of Science:

    • Rheumatology and Immunology
    • Pharmacology

    Background:

    • The fundamental nature of rheumatoid arthritis (RA) remains unclear, impacting rational cytotoxic drug use.
    • Current understanding suggests RA's immunological abnormalities may stem from persistent antigens, like microbial infections, rather than a primary immune disorder.

    Observation:

    • Cytotoxic drugs could reduce inflammation in RA.
    • However, their impact on immune responses is uncertain and potentially undesirable if RA is antigen-driven.
    • If RA is a primary immunoproliferative disorder, cytotoxic drugs might benefit from selective action on proliferating cells.

    Findings:

    • Evidence indicates cytotoxic drugs may enhance, not suppress, immune responses in rheumatic disease doses.
    • This challenges the conventional view of their immunosuppressive role in RA.

    Implications:

    • Rethinking the mechanism of action for cytotoxic drugs in rheumatoid arthritis is necessary.
    • Further research is needed to clarify RA's pathogenesis and optimize cytotoxic therapy.
    • Cytotoxic drugs may offer therapeutic benefits in RA through mechanisms beyond simple immunosuppression.

    Related Experiment Videos